Integer Holdings Co. (NYSE:ITGR) Director Sells $1,774,280.82 in Stock

Integer Holdings Co. (NYSE:ITGR - Get Free Report) Director Donald J. Spence sold 14,739 shares of the firm's stock in a transaction dated Wednesday, June 4th. The stock was sold at an average price of $120.38, for a total transaction of $1,774,280.82. Following the completion of the transaction, the director now directly owns 18,781 shares in the company, valued at approximately $2,260,856.78. This represents a 43.97% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Integer Trading Up 0.6%

Shares of ITGR traded up $0.70 during trading on Monday, reaching $122.03. 383,875 shares of the company traded hands, compared to its average volume of 375,849. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. The stock has a market cap of $4.26 billion, a PE ratio of 36.32, a price-to-earnings-growth ratio of 1.72 and a beta of 0.98. The stock has a 50-day simple moving average of $118.81 and a 200-day simple moving average of $128.02. Integer Holdings Co. has a twelve month low of $104.93 and a twelve month high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. The firm had revenue of $437.39 million during the quarter, compared to analysts' expectations of $428.51 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. The business's quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.14 earnings per share. On average, analysts anticipate that Integer Holdings Co. will post 6.01 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in ITGR. Mather Group LLC. grew its holdings in shares of Integer by 304.3% in the fourth quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 143 shares in the last quarter. Lee Danner & Bass Inc. acquired a new position in shares of Integer in the fourth quarter valued at approximately $27,000. AdvisorNet Financial Inc acquired a new position in shares of Integer in the first quarter valued at approximately $28,000. Opal Wealth Advisors LLC acquired a new position in Integer during the 1st quarter worth approximately $28,000. Finally, Bessemer Group Inc. grew its holdings in Integer by 73.1% during the 1st quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock worth $35,000 after acquiring an additional 125 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company's stock.

Wall Street Analyst Weigh In

ITGR has been the topic of a number of analyst reports. Citigroup raised shares of Integer from a "hold" rating to a "strong-buy" rating and lifted their target price for the stock from $133.00 to $140.00 in a research note on Thursday, May 22nd. Benchmark reduced their target price on shares of Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a research note on Friday, April 25th. KeyCorp reduced their target price on shares of Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research note on Monday, April 21st. Wall Street Zen raised shares of Integer from a "sell" rating to a "hold" rating in a research note on Monday, May 19th. Finally, Oppenheimer downgraded shares of Integer from an "outperform" rating to a "market perform" rating in a research note on Friday, February 21st. Two analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Integer presently has an average rating of "Moderate Buy" and a consensus target price of $145.00.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.